Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

2(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Detailed Status

Completed2

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 12 (100.0%)

Trials by Status

active_not_recruiting133%

completed267%

Recent Activity

1 active trials

Showing 3 of 3

active_not_recruiting

Imaging mGluR5 and Synaptic Density in Psychiatric Disorders

NCT03898297

completedphase_1

PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration

NCT02447640

completedphase_1

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

NCT00870974

Clinical Trials (3)

Showing 3 of 3 trials

NCT03898297

Imaging mGluR5 and Synaptic Density in Psychiatric Disorders

Active Not Recruiting

NCT02447640Phase 1

PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration

Completed

NCT00870974Phase 1

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

Completed

All 3 trials loaded

Drug Details

Intervention Type: RADIATION
Total Trials: 3